{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"SciSparc Ltd."},"Symbol":{"label":"Symbol","value":"SPRC"},"Address":{"label":"Address","value":"20 RAUL WALLENBERG STREET,TOWER A, 2ND FLOOR, TEL AVIV, 6971916, Israel"},"Phone":{"label":"Phone","value":"+972 37175777"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Middle East"},"CompanyDescription":{"label":"Company Description","value":"SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority."},"CompanyUrl":{"label":"Company Url","value":"https://www.scisparc.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Adi Zuloff-Shani","title":"Chief Technology Officer"},{"name":"Oz Adler","title":"Chief Executive & Financial Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}